Global Mefloquine Market size is estimated to reach $412.3 million by 2027, growing at a CAGR of 4.1% during the forecast period 2022-2027. The growth of the Global Mefloquine Market is greatly fuelled by the upsurging international brand names of Mefloquine. Mefloquine is an antimalarial agent. Mefloquine has been administered with additional antimalarial drugs, with the objective of postponing drug resistance. International brand names of Mefloquine include Eloquine, Lariam, Laricam, Larimef, Malariquin, Malarium, Malarivent T, Mefliam, Meflon, Melophar, Mephaquin, Mequin, Suton, Tropicur and Vexam. Mefloquine (Lariam) is administered with food and with at least 240mL of water. When utilized for malaria prophylaxis, the dose needs to be consumed once weekly on the same day every week. If vomiting happens within 30 minutes subsequent to the dose, an added full dose needs to be provided.

Global Mefloquine Market Growth Drivers:

Establishment of Novel Organic Salts Based on Mefloquine is Driving the Growth of the Global Mefloquine Industry:

The development of novel pharmaceutical tools to effectively deal with tuberculosis is the order of the day owing to the accelerated development of resistant strains of Mycobacterium tuberculosis. As per World Health Organization (WHO), in 2020, approximately 10 million people fell sick with tuberculosis (TB) globally including 5.6 million men, 3.3 million women and 1.1 million children. The traditional treatment for multidrug-resistant tuberculosis (MDR-TB) may take up to 24 months and only 56% of the cases are successfully treated. Novel potential formulations of a remodeled medication, the antimalarial agent mefloquine (MFL), which was integrated with organic anions as chemical adjuvants have been recorded. Mefloquine may be utilized for malaria prophylaxis and also in combination with additional antimalarial drugs. Eight mefloquine organic salts were acquired by ion metathesis reaction between mefloquine hydrochloride ([MFLH][Cl]) and numerous organic acid sodium salts in high yields. One of the salts, mefloquine mesylate ([MFLH][MsO]), demonstrated raised water solubility in comparison with [MFLH][Cl]. The establishment of novel organic salts based on Mefloquine is therefore driving the growth of the Global Mefloquine Industry, thereby contributing to the Global Mefloquine Industry Outlook.

For More Queries About "Mefloquine Market" @ https://www.industryarc.com/support.php?id=511483

Recognition of Mefloquine as a Potential Medication to Fight COVID-19 (Coronavirus) is Propelling the Growth of the Global Mefloquine Market:

Long-term malaria prophylaxis with weekly mefloquine has been investigated, Mefloquine may communicate with additional antimalarial drugs and antiseizure drugs. In July 2021, researchers in Japan suggested that the antimalarial agent mefloquine could be remodeled to efficiently treat SARS-CoV-2. As per the lead scientist in the team, Dr. Koichi Watashi, mefloquine had the highest anti-SARS-CoV-2 action among the tested compounds. The team examined the possibility of integrating mefloquine with nelfinavir which restricts the replication step of SARS-CoV-2. They noticed that the two medications acted in “synergy”. They estimated that mefloquine could decrease the complete viral load in affected patients to under seven percent and diminish the ‘time-till-virus-elimination’ by 6.1 days. The recognition of Mefloquine as a potential medication to fight COVID-19 (Coronavirus) is propelling the growth of the Global Mefloquine Market.

Investment:

In March 2019, Bayer Zydus Pharma planned to persist to finance novel medications. The firm is gratified with the performance of its equal joint venture (JV) with Zydus Cadila, as indicated by the official.

Global Mefloquine Market: Competitive Landscape

Key companies holding major shares in the Global Mefloquine Market are Toronto Research Chemicals, Alfa Chemistry, Waterstone Technology, 2A PharmaChem, 3B Scientific, Chembest Research Laboratories, Ningbo Taikang Chemical, Hangzhou J&H Chemical, Ningbo Taikang Chemical and Zydus Cadila.
To request for a quote, provide your details in the below link: https://www.industryarc.com/reports/request-quote?id=511483

Media Contact:

Mr. Venkat Reddy
Sales Manager
Email: [email protected]
Contact Sales: +1-970-236-3677

About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.